Barely Significant
← all phrases

“a nonsignificant trend”

5,407 sentences · 5,407 papers · 7,516 search hits before verification · confirmed specimen

Sighted at

p<0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

30 We found a nonsignificant trend for increased risk of cardiovascular mortality after FN, congruous with a recent review on how acute infections are associated with increased cardiovascular mortality. 13 The major strength of this study was the combination of nationwide clinical data generated through routine clinical care and data from the Danish health registries that facilitates almost complete ascertainment of outcomes and follow‐up.
19 – 22 A systematic Cochrane review found that antimicrobial therapy did not affect mortality in mild cases; however, there was a nonsignificant trend toward expedited resolution of illness. 23 In general, if symptoms are significant enough to come to clinical attention, and the diagnosis is suspected, the patient should receive antimicrobial treatment.
However, compared to the included group, excluded children had a higher proportion of European (vs non-European) children, a nonsignificant trend for a lower proportion of Asian children, and a nonsignificant trend for higher proportions of children from low and middle (vs high) socioeconomic backgrounds. 1.2.
57 A Cochrane review showed that nebulized magnesium sulfate provided significant improvement in pulmonary function tests and a nonsignificant trend to decreased hospital admission rates in severe asthma exacerbations, but no statistically significant difference when included in all severities of asthma attacks. 58 Inhaled magnesium sulfate is given as the diluent in place of normal saline (usually 2.5 mL of a 250 mmol/L solution) combined with salbutamol and ipratropium bromide in the same nebulized mask.
Common pediatric respiratory emergencies.
Emerg Med Clin North Am · 2012 · PMC7132755
However, there was a nonsignificant trend toward milder presentation and course in the edoxaban group. 22 Overall A meta-analysis pooling the results of all four pivotal clinical trials in patients with NVAF (RE-LY, ROCKET AF, ARISTOTLE, and ENGAGE AF-TIMI 48) included 42,411 patients receiving a DOAC and 29,272 patients receiving a VKA. 23 DOACs had a nonsignificant reduction in rates of major bleeding overall (HR 0.86; 95% CI 0.73–1.00; P =0.06) with significant reductions in hemorrhagic stroke (HR 0.49; 95% CI 0.38–0.64; P <0.0001) and intracranial hemorrhage (HR 0.49; 95% CI 0.39–0.59; P <0.0001) compared to VKA.